URGN Archived Articles
UroGen Pharma Ltd. (NASDAQ:URGN): A Promising Biotech Player Pioneering Novel Urology Treatments
Published on March 11, 2025
UroGen Pharma Ltd.: Positioning for Significant Growth with Promising Pipeline and Approved Product
Published on September 24, 2024